General Guideline Principles for NMDA Receptor/Antagonists for CRPS for workers compensation patients

The guidelines from the New York State Workers Compensation Board are designed to aid physicians, podiatrists, and other healthcare professionals in administering suitable treatment for NMDA Receptor/Antagonists for Complex Regional Pain Syndrome (CRPS).

These guidelines serve as a resource to help healthcare professionals make informed decisions about the optimal level of care for patients with Complex Regional Pain Syndrome . It’s essential to note that these guidelines do not replace clinical judgement or professional expertise. The ultimate decision regarding care should be collaboratively made by the patient in consultation with their healthcare provider.


NMDA Receptor/Antagonists for CRPS

The use of NMDA Receptor/Antagonists for Complex Regional Pain Syndrome (CRPS) is not recommended. This includes drugs such as dextromethorphan, as they are not advised for the treatment of CRPS.


What our office can do if you have workers compensation NMDA Receptor/Antagonists for CRPS

We’re here with the expertise to assist you with your workers’ compensation injuries. We comprehend the challenges you’re facing and are committed to addressing your medical needs, adhering to the guidelines established by the New York State Workers Compensation Board.

We recognize the significance of your workers’ compensation cases. Allow us to guide you through the complexities of dealing with the workers’ compensation insurance company and your employer.

We understand that this is a demanding period for you and your family. If you’re interested in scheduling an appointment, please reach out to us, and we’ll make every effort to ensure the process is as straightforward for you as possible.

Skip to content